Denosumab and muscle performance
Standard
Denosumab and muscle performance. / Rolvien, Tim; Rupp, Tobias; Strahl, André; Amling, Michael.
In: OSTEOPOROSIS INT, Vol. 34, No. 1, 01.2023, p. 211-212.Research output: SCORING: Contribution to journal › Letter › Research › peer-review
Harvard
Rolvien, T, Rupp, T, Strahl, A & Amling, M 2023, 'Denosumab and muscle performance', OSTEOPOROSIS INT, vol. 34, no. 1, pp. 211-212. https://doi.org/10.1007/s00198-022-06587-5
APA
Rolvien, T., Rupp, T., Strahl, A., & Amling, M. (2023). Denosumab and muscle performance. OSTEOPOROSIS INT, 34(1), 211-212. https://doi.org/10.1007/s00198-022-06587-5
Vancouver
Rolvien T, Rupp T, Strahl A, Amling M. Denosumab and muscle performance. OSTEOPOROSIS INT. 2023 Jan;34(1):211-212. https://doi.org/10.1007/s00198-022-06587-5
Bibtex
@article{9e03c96b9d8643959bcaf66b8df0021c,
title = "Denosumab and muscle performance",
author = "Tim Rolvien and Tobias Rupp and Andr{\'e} Strahl and Michael Amling",
year = "2023",
month = jan,
doi = "10.1007/s00198-022-06587-5",
language = "English",
volume = "34",
pages = "211--212",
journal = "OSTEOPOROSIS INT",
issn = "0937-941X",
publisher = "Springer London",
number = "1",
}
RIS
TY - JOUR
T1 - Denosumab and muscle performance
AU - Rolvien, Tim
AU - Rupp, Tobias
AU - Strahl, André
AU - Amling, Michael
PY - 2023/1
Y1 - 2023/1
U2 - 10.1007/s00198-022-06587-5
DO - 10.1007/s00198-022-06587-5
M3 - Letter
C2 - 36378303
VL - 34
SP - 211
EP - 212
JO - OSTEOPOROSIS INT
JF - OSTEOPOROSIS INT
SN - 0937-941X
IS - 1
ER -
